North America Epinephrine Market
Historic Data:    |   Base Year: 2023   |   Forecast Period: 2024-2031
to 2027 - Regional Analysis and Forecasts by Product Type (Prefilled Syringes, Auto-Injectors, Ampoules and Vials); Application (Anaphylaxis, Superficial Bleeding, Respiratory Disorders, Cardiac Arrest); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies); and Country

No. of Pages: 126    |    Report Code: TIPRE00009746    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
North America Epinephrine Market
Free Sample Buy Now

1. Introduction

1.1 Business Market Insights Research Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights
2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
  • 3.2.1 Hypothesis formulation:
  • 3.2.2 Macro-economic factor analysis:
  • 3.2.3 Developing base number:
  • 3.2.4 Data Triangulation:
  • 3.2.5 Country level data:

4. North America Epinephrine Market Landscape

4.1 Market Overview
4.2 Porter's Five Forces Analysis
  • 4.2.1 Bargaining Power of Suppliers
  • 4.2.2 Bargaining Power of Buyers
  • 4.2.3 Threat of New Entrants
  • 4.2.4 Competitive Rivalry
  • 4.2.5 Threat of Substitutes
4.3 Ecosystem Analysis
  • 4.3.1 Raw Material Suppliers
  • 4.3.2 Manufacturers
  • 4.3.3 Distributors/Suppliers
  • 4.3.4 End Users

5. North America Epinephrine Market – Key Market Dynamics

5.1 Growth Drivers
  • 5.1.1 Increasing Number of Anaphylaxis Cases
5.2 Market Opportunities
  • 5.2.1 Growing Pipeline of Epinephrine
5.3 Future Trends
  • 5.3.1 Introduction of generic version of epinephrine
5.4 Impact of Drivers and Restraints

6. North America Epinephrine Market Regional Analysis

6.1 North America Epinephrine Market Overview
6.2 North America Epinephrine Market Revenue 2017-2027 (US$ Million)
6.3 North America Epinephrine Market Forecast Analysis

7. North America Epinephrine Market Analysis – by Product Type

7.1 Prefilled Syringes
  • 7.1.1 Overview
  • 7.1.2 Prefilled Syringes: North America Epinephrine Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Auto-Injectors
  • 7.2.1 Overview
  • 7.2.2 Auto-Injectors: North America Epinephrine Market – Revenue and Forecast to 2031 (US$ Million)
7.3 Ampoules and Vials
  • 7.3.1 Overview
  • 7.3.2 Ampoules and Vials: North America Epinephrine Market – Revenue and Forecast to 2031 (US$ Million)

8. North America Epinephrine Market Analysis – by Application

8.1 Anaphylaxis
  • 8.1.1 Overview
  • 8.1.2 Anaphylaxis: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)
8.2 Superficial Bleeding
  • 8.2.1 Overview
  • 8.2.2 Superficial Bleeding: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)
8.3 Respiratory Disorders
  • 8.3.1 Overview
  • 8.3.2 Respiratory Disorders: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)
8.4 Cardiac Arrest
  • 8.4.1 Overview
  • 8.4.2 Cardiac Arrest: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

9. North America Epinephrine Market Analysis – by Distribution Channel

9.1 Retail Pharmacies
  • 9.1.1 Overview
  • 9.1.2 Cardiac Arrest: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)
9.2 Hospital Pharmacies
  • 9.2.1 Overview
  • 9.2.2 Cardiac Arrest: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)
9.3 Online Pharmacies
  • 9.3.1 Overview
  • 9.3.2 Cardiac Arrest: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)

10. North America Epinephrine Market – North America Analysis

10.1 North America
  • 10.1.1 North America Epinephrine Market Breakdown, by Key Country, 2020 and 2027 (%)
  • 10.1.1.1 North America Epinephrine Market – Revenue and Forecast Analysis – by Country
  • 10.1.1.1 US: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.1.1 US: North America Epinephrine Market Breakdown, by Product Type
    • 10.1.1.1.2 US: North America Epinephrine Market Breakdown, by Application
    • 10.1.1.1.3 US: North America Epinephrine Market Breakdown, by Distribution Channel
  • 10.1.1.2 Canada: North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.2.1 Canada: North America Epinephrine Market Breakdown, by Product Type
    • 10.1.1.2.2 Canada: North America Epinephrine Market Breakdown, by Application
    • 10.1.1.2.3 Canada: North America Epinephrine Market Breakdown, by Distribution Channel
  • 10.1.1.3 Mexico : North America Epinephrine Market – Revenue and Forecast to 2027 (US$ Million)
    • 10.1.1.3.1 Mexico : North America Epinephrine Market Breakdown, by Product Type
    • 10.1.1.3.2 Mexico : North America Epinephrine Market Breakdown, by Application
    • 10.1.1.3.3 Mexico : North America Epinephrine Market Breakdown, by Distribution Channel

11. Competitive Landscape

11.1 Heat Map Analysis
11.2 Company Positioning and Concentration

12. North America Epinephrine Market Industry Landscape

12.1 Overview
12.2 Mergers and Acquisitions
12.3 Agreements, Collaborations, and Joint Ventures
12.4 New Product Launches
12.5 Expansions and Other Strategic Developments

13. Company Profiles

13.1 Mylan N.V.
  • 13.1.1 Key Facts
  • 13.1.2 Business Description
  • 13.1.3 Products and Services
  • 13.1.4 Financial Overview
  • 13.1.5 SWOT Analysis
  • 13.1.6 Key Developments
13.2 Teva Pharmaceuticals Ltd.
  • 13.2.1 Key Facts
  • 13.2.2 Business Description
  • 13.2.3 Products and Services
  • 13.2.4 Financial Overview
  • 13.2.5 SWOT Analysis
  • 13.2.6 Key Developments
13.3 Amneal Pharmaceuticals LLC
  • 13.3.1 Key Facts
  • 13.3.2 Business Description
  • 13.3.3 Products and Services
  • 13.3.4 Financial Overview
  • 13.3.5 SWOT Analysis
  • 13.3.6 Key Developments
13.4 ALK-Abelló A/S
  • 13.4.1 Key Facts
  • 13.4.2 Business Description
  • 13.4.3 Products and Services
  • 13.4.4 Financial Overview
  • 13.4.5 SWOT Analysis
  • 13.4.6 Key Developments
13.5 Abbott
  • 13.5.1 Key Facts
  • 13.5.2 Business Description
  • 13.5.3 Products and Services
  • 13.5.4 Financial Overview
  • 13.5.5 SWOT Analysis
  • 13.5.6 Key Developments
13.6 Kaleo, Inc
  • 13.6.1 Key Facts
  • 13.6.2 Business Description
  • 13.6.3 Products and Services
  • 13.6.4 Financial Overview
  • 13.6.5 SWOT Analysis
  • 13.6.6 Key Developments
13.7 BIOPROJET
  • 13.7.1 Key Facts
  • 13.7.2 Business Description
  • 13.7.3 Products and Services
  • 13.7.4 Financial Overview
  • 13.7.5 SWOT Analysis
  • 13.7.6 Key Developments
13.8 Medeca Pharma AB
  • 13.8.1 Key Facts
  • 13.8.2 Business Description
  • 13.8.3 Products and Services
  • 13.8.4 Financial Overview
  • 13.8.5 SWOT Analysis
  • 13.8.6 Key Developments
13.9 Novartis AG
  • 13.9.1 Key Facts
  • 13.9.2 Business Description
  • 13.9.3 Products and Services
  • 13.9.4 Financial Overview
  • 13.9.5 SWOT Analysis
  • 13.9.6 Key Developments
13.10 Erythpharm
  • 13.10.1 Key Facts
  • 13.10.2 Business Description
  • 13.10.3 Products and Services
  • 13.10.4 Financial Overview
  • 13.10.5 SWOT Analysis
  • 13.10.6 Key Developments

14. Appendix

14.1 About Business Market Insights

The List of Companies - North America Epinephrine Market

The List of Companies - North America Epinephrine Market

  1. Mylan N.V.
  2. Teva Pharmaceuticals Ltd.
  3. Amneal Pharmaceuticals LLC
  4. ALK-Abelló A/S
  5. Abbott
  6. Kaleo, Inc
  7. BIOPROJET
  8. Medeca Pharma AB
  9. Novartis AG
  10. Erythpharm

 

north-america-epinephrine-market